Journal of Clinical Oncology
|Journal of Clinical Oncology|
Abbreviated title (ISO 4)
|J. Clin. Oncol.|
|1983 - present|
|Frequency||3 issues per month|
The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2012 impact factor of 18.038. JCO now accounts for nearly one in 10 of all oncology journal citations. Medical professionals from every subspecialty within the oncologic community make up the journal’s primary audience, and worldwide it has more than 26,000 subscribers.
Coden: JCONDN, LCCN: 84008124 and 82002854, (OCoLC)8320014, online issn: 1527-7755
This journal's focus is work that relates to the care of patients with cancer, i.e., clinical oncology. JCO publishes clinical research articles including Phase I, II, and III drug trials, review articles, meta-analyses, case reports, editorials, and grand rounds. All original research the journal publishes is geared toward the clinical side of oncology, meaning research which has an impact on the treatment and diagnosis of cancer, rather than research of a purely theoretical nature.
JCO publishes in multiple formats that include online, mobile, print, and podcast.
Online: Every Monday new articles are posted under the heading “Early Release.” The full text of all articles is available to subscribers online before publication in the print edition.
The JCO legacy archive comprises every print article from the journal’s January 1, 1983 launch to the present. All articles older than one year are freely available to the public.
Mobile: Facsimiles of the print version are available for viewing on mobile handheld devices.
Podcast: Podcasts are produced several times a month to accompany select articles. 
Editor-in-Chief: Stephen A. Cannistra, MD, serves as the Editor-in-Chief of JCO. He is a Professor in the department of Medicine at Harvard Medical School; the Director of Gynecologic Medical Oncology at Beth Israel Deaconess Medical Center in Boston, MA; an Attending Physician in the Medical Oncology Service at Dana-Farber Cancer Institute. He earned his Bachelor of Science and Medical degree from Brown University (1976 & 1979 respectively). He completed his internship and residency at Johns Hopkins in 1982 and completed fellowships at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute in Oncology in Boston, Massachusetts in 1985. He holds board certifications from the American Board of Internal Medicine and the American Board of Internal Medicine (Medical Oncology).
Emeriti Editors-in-Chief: Daniel G. Haller, MD, Philadelphia, PA (2001-2011) George P. Canellos, MD, Boston, MA (1988 - 2001) Joseph R. Bertino, MD, New Brunswick, NJ (1983 - 1988)
JCO currently maintains a roster of two Deputy Editors, 17 Associate Editors, and four Consulting Editors who range in location from Rotterdam in the Netherlands to Melbourne, Australia and from Dallas, Texas to Toronto in Ontario, Canada.
In 1981 Dr. Emil Frei III proposed that the American Society of Clinical Oncology should publish an official journal and that it should be called Journal of Clinical Oncology.
January 1, 1983, JCO Volume 1 Issue 1 rolled out, containing 70 pages of research and an editorial by the then Editor-in-Chief Dr. Bertino. In his editorial Dr. Bertino stated that, “The aim of the Journal of Clinical Oncology is to be a focus for communication for research pertaining to the clinical disciplines of oncology.” He also affirmed Journal of Clinical Oncology’s commitment to quick publication, stating, “We expect that full papers should be published within 6 months of receipt if deemed to be acceptable without revision or with minor revision.”
In 1987 George P. Canellos, MD, took over the position of Editor-in-Chief and led the push to make Journal of Clinical Oncology an international journal. In 1998 he realized his ambition with the Spanish language edition of JCO, which published quarterly, to be followed by a Chinese language edition.  Currently JCO produces 10 international editions.
Dr. Daniel Haller took the reins of the editorship in 2001 and during his tenure oversaw a move away from JCO’s commercial publisher Grune & Stratton11 to in-house publication by ASCO staff.2 During 2004, Dr. Haller also oversaw a major redesign of the journal’s cover and general look.
Currently, Dr. Stephen Cannistra serves as Editor-in-Chief. He has characterized his vision for JCO’s continuing direction as, “seeking out ways to maximize our ability to attract the best practice-changing and population-based oncology research and play a greater educational role in the process of clinical investigation."
Abstracting and indexing
- Thomson Reuters indices:
- Excerpta medica
- Index medicus
- Chemical abstracts
- Announcements page, from the Journal of Clinical Oncology Web site. Accessed August 5, 2009.
- JCO Circulationfrom the Journal of Clinical Oncology website. Accessed May 2, 2014.
- Journal Scope, from the Journal of Clinical Oncology website. Accessed April 30, 2014.
- Publication Dates, from the Journal of Clinical Oncology Website. Accessed May 9, 2014
- Editorial RosterFrom the Journal of Clinical Oncology website. Accessed May 9, 2014.
- Manuscript Categories
- Dana Farber/Harvard Cancer Center Profile Page
- ASCO Press Release, December 7, 2010.
- Beth Israel Deaconess 'Find a Doctor' Cannistra, Stephen A.
- PDF of first JCO article.
- JCO Editorial Board List
- PDF of JCO volume 1 issue 1
- History of the Journal of Clinical Oncology
- Editorial Board and International Editions From JCO.org. Accessed May 9, 2014.
- Silver Anniversary Timeline http://jco.ascopubs.org/anniversary/timeline.dtl
- Library catalog record. Harvard University. 2010.
- Master List. Thomson Reuters. December 2010.